Abstract

Hydroxychloroquine (HCQ) is an antimalarial agent that is commonly used to treat rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The present report documents a case of hypoglycaemia due to HCQ in a patient with SLE and diabetes mellitus type 2, in which the HCQ completely replaced the need for daily subcutaneous insulin.

Original languageEnglish (US)
JournalBMJ case reports
DOIs
StatePublished - Mar 2 2009

Fingerprint

Hydroxychloroquine
Systemic Lupus Erythematosus
Pharmaceutical Preparations
Antimalarials
Hypoglycemia
Type 2 Diabetes Mellitus
Rheumatoid Arthritis
Insulin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{02ac18b6b2ea411fbbbb4697765bb753,
title = "Hydroxychloroquine: A diabetic drug in disguise?",
abstract = "Hydroxychloroquine (HCQ) is an antimalarial agent that is commonly used to treat rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The present report documents a case of hypoglycaemia due to HCQ in a patient with SLE and diabetes mellitus type 2, in which the HCQ completely replaced the need for daily subcutaneous insulin.",
author = "Kang, {Lydia Y} and Mikuls, {Ted R} and O'Dell, {James Robert}",
year = "2009",
month = "3",
day = "2",
doi = "10.1136/bcr.08.2008.0654",
language = "English (US)",
journal = "BMJ Case Reports",
issn = "1757-790X",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Hydroxychloroquine

T2 - A diabetic drug in disguise?

AU - Kang, Lydia Y

AU - Mikuls, Ted R

AU - O'Dell, James Robert

PY - 2009/3/2

Y1 - 2009/3/2

N2 - Hydroxychloroquine (HCQ) is an antimalarial agent that is commonly used to treat rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The present report documents a case of hypoglycaemia due to HCQ in a patient with SLE and diabetes mellitus type 2, in which the HCQ completely replaced the need for daily subcutaneous insulin.

AB - Hydroxychloroquine (HCQ) is an antimalarial agent that is commonly used to treat rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The present report documents a case of hypoglycaemia due to HCQ in a patient with SLE and diabetes mellitus type 2, in which the HCQ completely replaced the need for daily subcutaneous insulin.

UR - http://www.scopus.com/inward/record.url?scp=84886095389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886095389&partnerID=8YFLogxK

U2 - 10.1136/bcr.08.2008.0654

DO - 10.1136/bcr.08.2008.0654

M3 - Article

C2 - 21686697

AN - SCOPUS:84886095389

JO - BMJ Case Reports

JF - BMJ Case Reports

SN - 1757-790X

ER -